Search Results 11-20 of 12759 for ���������������������������op������r���:za33���
The purpose of this trilal is to study a combination of neoadjuvant radiotherapy (RT), immunotherapy (pembrolizumab) and chemotherapy for lymph node-positive, ...
To evaluate the efficacy and safety of lenalidomide, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R2-CHOP) chemotherapy versus placebo ...
The purpose of this study is to compare the effectiveness and safety of the humanized monoclonal anti CD19 antibody tafasitamab plus lenalidomide in addition to ...
They include magnetic resonance imaging, subtraction ictal SPECT coregistered to MRI (SISCOM), electroencephalography, ketogenic diet, deep brain stimulation, ...
... (R/R DLBCL). Print details. Share; Facebook · Twitter. Overview; Participation ... (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). Participation eligibility.
International Journal of Surgery. 2022; doi:10.1016/j.ijsu. 2022.106633 . Simon R. Complications after pancreaticoduodenectomy. Surgical Clinics of North ...
PM R 2024 Jun; 16 (6):605-625 Epub 2024 Jan 12. View PubMed; Prusinski C, Yan D, Klasova J, McVeigh KH, Shah SZ, Fermo OP, Kubrova E, Farr EM, Williams LC ...
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma · Overview · Participation eligibility · Participating Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.